Informed Comment Homepage

Thoughts on the Middle East, History and Religion

Header Right

  • Featured
  • US politics
  • Middle East
  • Environment
  • US Foreign Policy
  • Energy
  • Economy
  • Politics
  • About
  • Archives
  • Submissions

© 2025 Informed Comment

  • Skip to content
  • Skip to primary sidebar
Drugs

Big Pharma spent more on Stock Buybacks and Dividends than on Research and Development even during COVID

F. Douglas Stephenson 01/08/2023

Tweet
Share
Reddit
Email

Gainesville, Florida (Special to Informed Comment) – The 14 largest publicly-traded pharmaceutical companies spent $747 billion on stock buybacks and dividends from 2012 through 2021 — substantially more than the $660 billion they spent on research and development. So argue economists William Lazonick, professor emeritus of economics at University of Massachusetts, and Öner Tulum, a researcher at Brown University, in a new paper.

Recently Big Pharma bluntly and unashamedly announced price hikes in the United States on more than 350 drugs while continuing to brazenly insist that large price hikes are necessary for innovation. The Lazonick/Tulum research shows that the business model of America’s largest pharmaceutical companies involves far more spending on enriching shareholders and executives than on research and development.

Big business, Big Insurance and Big Pharma industries dominate our government with public health taking a back seat to the need for large private profit. Many government leaders from both political parties share the same ‘profits over public health’ ideology, even though the Covid-19 pandemic clearly showed how our economic system failed to serve our citizens by allowing these groups to privatize, sabotage, fragment and cripple our health, public health and other social services.

No greater disconnect exists between the public good and private interests than in the U.S. system of monopoly, for-profit Big Pharma.

Over forty years of profiteering by Big Pharma and oligarch control of our economy left the public totally exposed and ill-prepared to face the public health crisis of COVID-19. Because Big Pharma rarely invests in prevention, it has very little motivation to invest in preparedness for a public health crisis. Drugs for prevention do not contribute to share-holder value and profit. Instead, cures are designed once a public health crisis strikes.

The sicker we are the more profit they earn.

Filed Under: Drugs, Health Care, Inequality, Neoliberalism, Pharmaceuticals, Plutocracy, Poverty, Taxes

About the Author

F. Douglas Stephenson , LCSW, is a retired psychotherapist and former instructor of social work in the University of Florida Department of Psychiatry. He is a member of Physicians for a National Health Program.

Primary Sidebar

Support Independent Journalism

Click here to donate via PayPal.

Personal checks should be made out to Juan Cole and sent to me at:

Juan Cole
P. O. Box 4218,
Ann Arbor, MI 48104-2548
USA
(Remember, make the checks out to “Juan Cole” or they can’t be cashed)

STAY INFORMED

Join our newsletter to have sharp analysis delivered to your inbox every day.
Warning! Social media will not reliably deliver Informed Comment to you. They are shadowbanning news sites, especially if "controversial."
To see new IC posts, please sign up for our email Newsletter.

Social Media

Bluesky | Instagram

Popular

  • The Day Evin Prison Burned: Why Israel's Attack Crossed a Moral Line
  • America's worsening Solar Gap with China, which installs 100 Panels per Second
  • How Zohran Mamdani’s win in the New York City mayoral Primary could Ripple across the Country
  • Netanyahu's 'New Middle East:' Same old Colonialism
  • Early Farming in Middle East, Sometimes Matriarchal, Spread through Learning, not Conquest

Gaza Yet Stands


Juan Cole's New Ebook at Amazon. Click Here to Buy
__________________________

Muhammad: Prophet of Peace amid the Clash of Empires



Click here to Buy Muhammad: Prophet of Peace amid the Clash of Empires.

The Rubaiyat of Omar Khayyam


Click here to Buy The Rubaiyat.
Sign up for our newsletter

Informed Comment © 2025 All Rights Reserved